(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

XANTHOPHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

XANTHOPHARMA

ST13

US500000075573896

Class

1, 5

Filing

75573896

Registration

2411775

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

05/02/2025

Trademark type

Word

Nice classes

1, 5

Filing date

10/20/1998

Registration date

12/12/2000

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/20/2021

Last transaction

05/02/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/19/1999

First use in commerce

03/19/1999

Drawing code

1

Owner type

03

Owner location

Quito; Pichincha, EC

Examiner

POWERS, ALEXANDER

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

I. C. (pessoa física)
I. C. (pessoa física)

Representatives

Steven D. Lustig Panitch Schwarze Belisario & Nadel LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Blends in edible vegetable oils of xanthophyll and marigold extracts for use in the manufacture of dietary and nutritional supplementsfoodsfeedstuffs and cosmetics

Class 5

Blends in edible vegetable oils of xanthophyll and marigold extracts for use as dietary and nutritional supplements

Publications

History of USPTO decisions and trademark events.

35 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/30/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/30/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/30/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/02/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/02/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/02/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/02/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/02/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/02/2025

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/20/2021

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

03/20/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/20/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/20/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

12/09/2020

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

12/17/2010

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/17/2010

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/17/2010

E89R

TEAS SECTION 8 & 9 RECEIVED

12/08/2010

CFIT

CASE FILE IN TICRS

07/20/2006

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

07/12/2006

PLGL

ASSIGNED TO PARALEGAL

07/06/2006

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

04/13/2006

E815

TEAS SECTION 8 & 15 RECEIVED

04/13/2006

A7OK

AMENDMENT UNDER SECTION 7 - PROCESSED

05/09/2002

AMD7

SEC 7 REQUEST FILED

04/01/2002

MAIL

PAPER RECEIVED

04/01/2002

R.PR

REGISTERED-PRINCIPAL REGISTER

12/12/2000

PUBO

PUBLISHED FOR OPPOSITION

09/19/2000

NPUB

NOTICE OF PUBLICATION

08/18/2000

1.BD

Sec. 1(B) CLAIM DELETED

01/05/2000

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/06/1999

CNEA

EXAMINER'S AMENDMENT MAILED

11/24/1999

CNRT

NON-FINAL ACTION MAILED

05/24/1999

IUAF

USE AMENDMENT FILED

05/20/1999

DOCK

ASSIGNED TO EXAMINER

05/13/1999

Continuous trademark protection

Get notified about every new filing that threatens XANTHOPHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.